FDA Investigator Debra L Boyd Seale

Debra L Boyd Seale has inspections in 6 countries as of 14 Sep 2023. Debra L Boyd Seale has collaborated with a combinined 2551 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
54
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Poland, China, Spain, Taiwan, Czechia
Co-Investigator(s):
Adam J Taylor, Alan M Barker, Alicia M Mozzachio, Alla Dubrovsky, Amanda Dinaro, Amanda S Zorn, Andrea A Branche, Andrew A Hoopes, Andrew A Leboeuf, Anna Flynn, Anya D Lockett Evans, Benton M Ketron, Bradley J Maunder, Brian D Nicholson, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Carrie Ann Plucinski, Chad E Schmear, Chery Grandinetti, Chiang Syin, PhD, Christina A Miller, Christine I Shaw, Christopher D Leach, Colleen E Burke, Daniel C Kearns, Daniel Kearns, David K Glasgow, Debra Boyd Seale, Debra I Love, Denise L Burosh, Dr. Guang Gao, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Elliot P Cowam, PhD, Eric M Mueller, PharmD, Eric S Pittman, Eric S Rittman, Eric T Huebler, Erin M Mcdowell, Francis J Eng, Gene D Arcy, Gregory R Dill, Hala L Selby, Harperd, Helen B Ricalde, Humera Khan, Humera T Khan, James W Plucinski, Jan B Welch, Jan Welch, Jason F Chancey, Jayne E Holcomb, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer C Adams, Jennifer C Johnson, Jesse A Vazquez, Joan A Loreng, John A Iwen, John P Brooks, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Julie D Bringger, Karen Emasley Joseph, Karen Emaslwey Joseph, Karen M Cooper, Karen M Montgomery (KMM), Kathleen B Swat, Kathleen S Tormey, Kimberly Lewandowski Walker, Kristin M Abaonza, Kujtim Sadiku, Lagurta M Mayher, Lakisha M Williams, Lana K Waselewski, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Leeterry Moore, Lequita M Mayhew, Linda M Cheny, Lisa Hayka, Lisa Hornback, Lorelei S Jarrell, Marcia A Worley, Margaret Mtorres Vazquez, Margaret Torres Vazquez, Maria Diaz, Marijo B Kambere, PhD, Martha T Olone, Mathew T Thomas, MD, Matthew J Sienko, Maureen C Melvin, Michael D Robinson, Michael Serrano, Michele L Glendenning, Michele Perry Williams, Min Chu Chen, Min Lu, Nicholas F Lyons, Nicholas P Diorio, Nicholas Z Lu, Nicole C Victoria, PhD, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Niraj R Mehta, PhD, Norman Wong, Omotunde O Osunsanmi, Paola S Barnett, Patricia A Mcilroy, Paul M Chefor, Phung Thien Nguyen, Prabhu P Raju, Rachel E Mcguigan, Rafael Padilla, Rita K Kabaso, Robert J Ham, Robert L Stevenson, Roberta W Cunningham, Russell K Riley, Sarah B Tanksley, Shalonda C Clifford, Stephen D Eich, Susan A Zullo, PhD, Susan D Yuscius, Susan M Jackson, Susan Yuscius, Tamara Brey, Tamara M Qtami, Tamara Qtami, Teena H Aiken, Tenzin Jangchup, Theressa B Smith, Todd M Stankewicz, Tong Zhou, Uruaku A Obasi, Vickie J Kanion, Vioela J Caze, Yiyue Zhang (nmi), PhD, Yuanyuan Li

Debra L Boyd Seale's Documents

Publish Date Document Type Title
August, 2022 FDA 483 Patrick J. Stiff, M.D. - Form 483, 2022-08-05
October, 2018 EIR Experimur, A Frontage Company - EIR, 2018-10-26
April, 2019 FDA 483 Glen Sussman - Form 483, 2019-04-12
January, 2023 FDA 483 Madeleine Duvic, M.D. - Form 483, 2023-01-13
February, 2017 FDA 483 VIOS - Form 483, 2017-02-03
April, 2017 FDA 483 Della Valle, Craig - Form 483, 2017-04-10
September, 2019 FDA 483 Anuj Bhargava MD - Form 483, 2019-09-27
September, 2018 FDA 483 Sagent Pharmaceuticals Inc - Form 483, 2018-09-24
April, 2018 FDA 483 Uptown Research Institute - Form 483, 2018-04-13
April, 2018 FDA 483 Response Uptown Research Institute - Form 483R, 2018-04-19
September, 2016 FDA 483 Response Joseph R. Lentino, M.D. - Form 483R, 2016-10-10
July, 2020 FDA 483 Kathleen M. Mullane, D.O. - Form 483, 2020-07-20
September, 2016 FDA 483 Joseph R. Lentino, M.D. - Form 483, 2016-09-20
May, 2004 EIR Abbott Laboratories - EIR, 2004-05-12
April, 2018 EIR Uptown Research Institute - EIR, 2018-04-13
October, 2018 FDA 483 Response Experimur, A Frontage Company - Form 483R, 2018-11-19
January, 2019 FDA 483 Pau Montesinos, M.D. - Form 483, 2019-01-18
October, 2019 FDA 483 Response Astellas Pharma US Inc. - Form 483R, 2019-10-24
May, 2019 FDA 483 Pharmaron - Form 483, 2019-05-24
October, 2019 EIR Astellas Pharma US Inc. - EIR, 2019-10-04
February, 2020 FDA 483 Sunandana Chandra MD, Clinical Investigaor - Form 483, 2020-02-05
September, 2016 EIR Joseph R. Lentino, M.D. - EIR, 2016-09-20
October, 2018 FDA 483 Experimur, A Frontage Company - Form 483, 2018-10-26
August, 2019 FDA 483 Luis F. Soruco, MD - Form 483, 2019-08-23

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more